Business

Stocks Skyrocket Amid Potential COVID-19 Vaccine News

Jirapong Manustrong/Shutterstock

Daily Caller News Foundation logo
Jake Dima Contributor
Font Size:

U.S. stocks have skyrocketed as pharmaceutical company Pfizer announced that its potential coronavirus vaccine was 90% effective Monday.

The Dow jumped as much as 1,610 points around 9:30 a.m. before leveling off at around a 1,250 point gain (4.4%) at the time of publishing, according to CNN Business. The S&P 500 saw an uptick of 3.3% and the Nasdaq Composite increased by 1.3% amid the news, CNN reported.

Both the Dow and S&P 500 are on track for displaying one of the largest daily gains in the country’s history, according to CNN.

“I am happy to share with you that Pfizer and our collaborator, BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine,” Pfizer wrote in a statement. “The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.”

NEW YORK, NY - JULY 29: A man is reflected in a bus stop window as he walks past Pfizer world headquarters in Midtown Manhattan on July 29, 2019 in New York City. On Monday morning, Pfizer announced the merger of its off-patent drug business with generic drugmaker Mylan. The new combined company will be based in the United States and Mylans EpiPen and Pfizers Viagra will be among its portfolio of products. (Drew Angerer/Getty Images)

A man is reflected in a bus stop window as he walks past Pfizer world headquarters in Midtown Manhattan on July 29, 2019 in New York City (Drew Angerer/Getty Images).

The medical company also added that its mRNA-based vaccination has brought the company “one step closer” to a “much-needed breakthrough” to ultimately end the virus. (RELATED: Stocks Drop After Trump Announces Positive COVID Test)

“The results demonstrate that our mRNA-based vaccine can help prevent COVID-19 in the majority of people who receive it,” Pfizer wrote. “This means we are one step closer to potentially providing people around the world with a much-needed breakthrough to help bring an end to this global pandemic.”

“This is a first but critical step in our work to deliver a safe and effective vaccine.”

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact licensing@dailycallernewsfoundation.org.